Premium
US Stem Cell Inc (CE) (USRM)
USOTC
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Founded in 1999, U.S Stem Cell, Inc. is committed to the development of effective cell technologies to treat a variety of diseases and injuries. By harnessing the body's own healing potential, we may be able to reverse damaged tissue to normal function. U.S. Stem Cell's discoveries include multiple ... Founded in 1999, U.S Stem Cell, Inc. is committed to the development of effective cell technologies to treat a variety of diseases and injuries. By harnessing the body's own healing potential, we may be able to reverse damaged tissue to normal function. U.S. Stem Cell's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle. U.S Stem Cell is focused on regenerative medicine. While most stem cell companies use one particular cell type to treat a variety of diseases, U.S Stem Cell utilizes various cell types to treat different diseases. It is our belief that the unique qualities within the various cell types make them more advantageous to treat a particular disease. Show more
American Premium Water Corp. (HIPH) Distribution in GNC – General Nutrition Center Miami, FL -- March 22, 2018 -- InvestorsHub NewsWire -- EmergingGrowth.com, a leading independent...
After strengthening its balance sheet at the end of last year DryShips, Inc. (NASDAQ: DRYS), a diversified shipping company, planned to rebuild its depleted fleet and they have done exactly that...
Miami, FL -- InvestorsHub NewsWire -- April 12, 2017 -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the...
Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth Miami, FL--(InvestorsHub NewsWire – April 12, 2017) –...
AUSTIN, Texas, June 2, 2014 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Bioheart, Inc. (OTCQB:BHRT), a biotechnology company focused on the...
Bioheart to Present at Cell Therapy for Cardiovascular Disease Conference in New York /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a {...
SUNRISE, Fla., June 26, 2012 (GLOBE NEWSWIRE) -- Bioheart, Inc. (BHRT.OB) announced today that the company has launched a new brand image and redesigned website including a new company logo and...
SUNRISE, Fla., June 25, 2012 (GLOBE NEWSWIRE) -- Bioheart, Inc. (BHRT.OB) announced today that Kristin Comella, the company's Chief Science Officer presented at the 10th Annual Meeting of the...
SUNRISE, Fla., May 29, 2012 (GLOBE NEWSWIRE) -- Bioheart, Inc. (OTCBB:BHRT) announced today that it will offer another laboratory training course in partnership with the Ageless Regenerative...
SUNRISE, Fla., May 3, 2012 (GLOBE NEWSWIRE) -- Bioheart, Inc. (BHRT.OB) announced today that Mike Tomas, the company's President/CEO, has been named a 2012 Hall of Famer by Miami Dade College...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 2263152 | 3.507E-5 | CS |
| 4 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 1903001 | 7.923E-5 | CS |
| 12 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 767565 | 6.852E-5 | CS |
| 26 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 594231 | 6.852E-5 | CS |
| 52 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 462010 | 7.286E-5 | CS |
| 156 | -0.005999 | -99.9833333333 | 0.006 | 0.0119 | 1.0E-6 | 519955 | 0.00452688 | CS |
| 260 | -0.003799 | -99.9736842105 | 0.0038 | 0.08715 | 1.0E-6 | 1189899 | 0.02062228 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
